Pioneering Better Diagnostics

MagArray was founded in 2005 by Stanford professors who adapted magnetic sensing technology from the computer disk drive industry for use in medical diagnostics. MagArray technology builds upon the giant magnetoresistive (GMR) nanosensors used as read head elements in computer hard drives to detect biomolecules or biomarkers labeled with magnetic nanoparticles.

Using this pioneering technology, MagArray has developed a simple, ultra-sensitive, multiplex immunoassay system. Highly sensitive, the system overcomes limitations of other common clinical analysis technologies to deliver significant advantages to both laboratories and clinical assay designers.

The vision for our cutting edge CLIA laboratory includes expanding our platform to develop diagnostic tests for several cancers and allergies, as well as cardiovascular, infectious, and inflammatory diseases.

MagArray previously received early stage funding and support from the National Cancer Institute (NCI) in the U.S. It was also selected as a recipient of the prestigious and competitive Small Business Innovation Research (SBIR) Phase IIb Bridge Award. The company has forged strategic partnerships with world-class medical centers in the U.S. and with leading Global Fortune 500 companies to commercialize the magnetic nanosensor detection technology.